GATC Naturals, a GATC Health Licensee, Signs $1.2M Services Agreement

GATC Health Corp, a technology company revolutionizing drug discovery and disease prediction using artificial intelligence and advanced multiomics, today announced its licensees GATC Naturals Corp has signed a Master Exclusive Services Agreement with Self Health America Holdings, Inc., a leading medical technology company currently developing customized and personalized patient management solutions. As and where legally approved, the goal is to provide individualized, medically supervised and verified psilocybin reports. According to a recent ResearchandMarkets.com report, supervised clinical use of psychedelic drug therapy and related products is expected to nearly double from approximately $4.07 billion today to $7.58 billion by 2026.

GATC Health’s Multiomics Advanced Technology™ (MAT) and advanced artificial intelligence will serve as the platform for the psilocybin-specific “engine” used by GATC Naturals to produce the reports for Self Health America Holdings and its patient base. These reports, based on individual genetic analysis, will help medical personnel make personalized treatment recommendations where approved legally and permitted to do so. The agreement calls for $1.2 million in exclusivity fees, and an annual sales minimum of $1.4 million beginning 2024 to maintain exclusivity. All data collected by Self Health America Holdings and shared with GATC Naturals for analysis and reporting purposes will become the property of GATC Health, potentially adding considerable asset value to the company. Additionally, a significant portion of GATC Naturals’ revenues flow through to GATC Health per the companies’ license agreement.

*    *    *

About GATC HealthGATC Health Corp is a pioneering technology company using whole genome analysis and multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. The company’s patented AI platform reduces risk, time and costs for life science companies by digitally reproducing the human body to find non-obvious answers to biology’s most complex questions. GATC Health is accelerating healthcare’s transition to predictive, individualized medicine.Disclaimer

The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities.  This presentation contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information.  The Company reserves the right to modify or amend the information contained herein.